Via Instapundit and MIT Technology Review:
Harvard Apparatus Regenerative Technology, or HART, is testing its synthetic trachea system in Russia and has plans for similar tests in the European Union this year. The company is working with the U.S. Food and Drug Administration to set up a trial in the United States as well.
The synthetic windpipes are made by growing a patient’s own stem cells on a lab-made scaffold. In the future, this technique could be adapted to create other organs, such as a replacement esophagus, heart valve, or kidney.
Click the link to see more: Could Growing Patient Stem Cells on a Synthetic Scaffold Slash Organ Transplant Waiting Lists? | MIT Technology Review
Points:
Parallels:
Ponder:
Practice:
Predict:
Propose: